InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Haas Jason, 董事. Insider active across 2 companies, notably Ligand Pharmaceuticals INC. Aggregated, 12 disclosures have been published. Split: 1 buy · 2 sells. Total volume traded: €1.8m. History available since 29 June 2022. The latest transaction was filed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Jason Haas is Administrateur. He is linked to Syros Pharmaceuticals, Inc., where he is Chief Financial Officer, and to Ligand Pharmaceuticals INC, where he is Director. The 10 filings on record cover the period from 2022-06-30 to 2025-06-10, and the recent filings show mainly attributions.